Webinar: iPSCs - The Future of Disease Research

Webinar Title: iPSCs - The Future of Disease Research

Duration: 40 min Presentation + 20 mins for Q&A


For over a decade, we have worked with the European Collection of Authenticated Cell Cultures (ECACC), a part of Public Health England, to bring authenticated and quality controlled cell lines and nucleic acids to research laboratories around the world. ECACC is one of the premier collections of authenticated cell cultures in the world and includes cell lines originating from 45 different species, 50 tissue types, 300 HLA types, 450 monoclonal antibodies and at least 800 genetic disorders. As an extension of this partnership, we are now proud to offer the European Bank of Induced Pluripotent Stem Cells (EBiSC) to provide researchers with greater access to more than 350 patient-derived iPSC lines for disease modeling.

    
     

 What Does it Cover?

The development of human iPSC technology offers researchers the ability to more accurately generate physiologically relevant models of disease and normal tissues in the laboratory. Advances in iPSC generation have allowed many laboratories to make their own cell lines; however, researchers rarely have the resources needed to establish stocks, undertake quality control and share their own de novo iPSC cell lines with other laboratories. A pre-existing and established iPSC collection therefore allows iPSC researchers to obtain “off the shelf” access to a large, robust and reliable supply of iPS cell lines that represent diverse donor to donor variability and which include disease status normal controls and gene edited cell lines. iPSCs from ECACC are standardized and quality controlled and have the benefit of coming from a trusted and internationally recognized collection with worldwide distribution.
 

 What Will You Learn?

  • History and development of the EBiSC iPSC project
  • Variety of diseases represented in the collection
  • Applications of iPS cell lines
  • Availability of lines and how to access them

 Who Should Attend?

  • Stem cell researchers
  • Researchers working on disease modelling and pre-clinical research
  • Scientists interested in improving their cell models
  • Cell Biologists
  • Molecular Biologists
  • Toxicologists and Pharmacologists
Speaker Bio
Dr. Sharon Bahia
Product and Distributor Manager
The European Collection of Authenticated Cell Cultures (ECACC)
Porton Down, UK
Sharon has worked in the field of toxicology for over 15 years and with stem cells for the past 9 years. She has extensive knowledge of undertaking research in hospitals, academic laboratories, research institutes and pharmaceutical companies to better understand disease pathophysiology, investigate drug induced toxicity and develop personalised medicinal therapies. She is passionate about advising researchers on developing better in vitro models and over the last year Sharon has played a key role in the introduction and development ECACC's range of iPS cell lines.